Player is loading...

Embed

Embed code

Transcriptions

Note: this content has been automatically generated.
00:00:06
um so today i'll be talking to rouse solutions that the file
00:00:10
and what we want to be in what we aim to be is a fully independent solution
00:00:16
that's it's within the health economy to facilitate the shift value
00:00:21
based health care and improves aside the well being
00:00:24
we are trying to develop a global solution um and we have a
00:00:30
partnership with swiss calm while our technical and developmental partners to provide
00:00:36
us with the ball chain development will uh also joining the action checkup
00:00:41
and we also have some numerous uh industry partnerships as well
00:00:47
um so i'm i'm sure with the healthcare background y'all have you're all aware
00:00:52
of some of the main problems you know facing societies as a whole
00:00:57
health care yeah is faced with on sustainable expenditure and this is due to eighteen populations
00:01:04
rising prevalence of of chronic diseases and rising treatment costs
00:01:09
and we also see that healthcare is moving towards personalisation like the previous presenter has said
00:01:16
and this is resulted in in a barrier to market access for manufacturers for the innovative therapies
00:01:23
we see health authorities in shores can't afford to pay for these new high
00:01:28
cost therapies this also results in barriers to access for patients as well
00:01:34
so patients often the night these lifesaving therapies well they have to pay for therapies
00:01:40
it doesn't work and we see that this is quite an unfair system
00:01:47
and we see the who well there's moving forward value based health care and value
00:01:50
based uh health deals of being struck internationally of the last few years
00:01:57
let's take one example metro naked zero value basically isn't two thousand seventeen
00:02:02
in two thousand eighteen they have more than a thousand the like to estimate that more
00:02:07
than seventy five percent of health care payments by twenty twenty will be value based
00:02:14
and what is value based healthcare value based half k. is paying for performance
00:02:19
and no longer pay in for service or paying for volume
00:02:23
so we only pay the full price if the treatment gives good patient outcomes
00:02:31
but one of the main problems with we see with value based health
00:02:34
care and value based pricing is the infrastructure limitations of actually
00:02:39
implementing this and this is the main problem that we seek to
00:02:44
solve so some of the key problems is trusting transparency
00:02:49
because payment for health care is now based on outcomes it's all about
00:02:54
what the results of the treatments are these can easily be manipulated
00:02:58
by either party and this is one problem we currently see
00:03:02
there's also the privacy and security of these pricing agreements the administrative burden that's associated with
00:03:09
tracking patience patience start treatments at different times they reach different events in different times
00:03:16
and combining these with different pricing agreement as well the re conciliation is
00:03:21
it's quite a big administrative bit than an essentially the costs of doing this
00:03:26
negates all the cost benefit of actually moving to a value based approach
00:03:33
what we also see our technical limitations so the ability to follow patients as
00:03:39
they move across different treatment centres we also have issues with time delays
00:03:45
of reimbursement because of this currently in some countries
00:03:50
uh let's take i learned for example last year hepatitis c. patients were not able to get
00:03:56
treatment for a period of six to eight weeks 'cause there's a rebate mechanism in place
00:04:01
where at a manufacturer will hold a funds that they given by the player
00:04:07
until the outcomes are completely check through in the fine and then that a
00:04:12
discount or or refund the sent back and this is an unsustainable model
00:04:17
and we also see that there is no one single platform that anybody can use
00:04:22
so what did you farm we utilise blocking technology to create
00:04:26
that data integrity and a mute ability around outcomes
00:04:30
so everybody knows that this is the one true vision of events and
00:04:34
everybody within that network has a copy of of that uh data
00:04:41
we also understand that privacy and security of
00:04:45
pricing agreements is is key essentially
00:04:49
clinical trials data yes that's confidential but essential that that
00:04:52
that's always published into the public domain where
00:04:55
is next prices and discounts uh i things that the never essentially released into the public
00:05:02
and so we use private permission block chains well only those
00:05:06
actors within that network have access to that data
00:05:11
we also eliminated ministry to bit in using smart contract
00:05:15
so smart contracts a digital representations of physical
00:05:18
contracts well we can entities pricing agreements
00:05:21
and these are able to be executed automatically according to the data systems that these link
00:05:27
to so in healthcare this would be health information system or clinical data registry
00:05:33
we also use digital identities and not be spoke integration engines to be
00:05:37
able to track patients across different treatment centres and because combining all
00:05:43
of this were able to create is real time reinvestment in settlement
00:05:47
mechanisms on we're able to create this one single global platform
00:05:51
for farmer company they can use in every country day trying to gain access to and for
00:05:55
pay or they can use that to every manufacturer provider they have value based agreements with
00:06:03
so one of our flagship solutions is the real based platform and taking all that
00:06:08
i've said into account you can now create very complex and personalise pricing agreements
00:06:14
whether it's a price agreement for an oncology drug that's based on survival
00:06:18
well whether it's an agreement that include survival the serious adverse events of interest
00:06:24
a re hospital association rate or any other surrogate endpoint that's collected by some sort
00:06:29
of digital device no matter how many conditions you place in this agreement
00:06:34
the administrative been does not change and this is something that we see
00:06:38
is very important so we've set up our system to be fully
00:06:46
flexible fully customisable to work within any type of healthcare system whether
00:06:51
to single payer system like the u. k. n. h. s.
00:06:55
whether it's a and and uh but don't think shows base system like we seen sweets and
00:07:00
well we can also look at 'em systems where patients but don t. pay for their house cat
00:07:06
outright with out of pocket payments i i and this is an example of a manufacturer dashboard
00:07:14
so many factors and and anybody within the network is able to customise these platforms and
00:07:20
include the key performance indicators how they wish and we have certain access management facilities
00:07:26
so only for example if you are not pharmaceutical company only the the the pricing
00:07:32
team or the health economics team will be able to see this pricing
00:07:35
data rows of the you know clinical departments can actually see key product performance
00:07:40
and the other indicators so in regards to lodge any so far
00:07:46
um we have many pilots in planning with several international health authorities
00:07:54
um cross three conference continents um and we're in negotiations and discussions with certain pilots
00:08:01
what ate up the top ten pharmaceutical companies were also reaching it
00:08:05
to work with a community care providers and social care
00:08:08
as we see value based commissioning in that area is huge as essentially
00:08:13
eh in community can social care outcomes and not being tracked and these
00:08:18
are populations especially the elderly that have the highest cost within
00:08:23
uh for health systems uh and we're also working with
00:08:26
channel mic sequencing partners to get patients to participate
00:08:31
on some of our platforms to receive three gentlemen profiling i'll get that get to that later
00:08:38
i'm sorry lost our road map uprising platform will be ready within the next
00:08:42
four weeks ready to kick off pilots but the minimum bible network
00:08:48
um we hope to have three very significant large
00:08:52
scale pilots with the minimum bible network
00:08:55
uh by the end of two thought so completed by the end of two thousand
00:08:59
nineteen and a minimum bible network is is those for example uh uh pay a manufacturer
00:09:05
and uh provide that we'll have a series of smaller pilots when we need
00:09:10
um and we seek to have an international roll out by early two thousand nineteen as we are the first independent
00:09:17
a pricing platform uh on the market at the moment i so because we are able to
00:09:24
integrate and link into sits in health information systems
00:09:28
we want to provide patients you opportunity
00:09:32
to be rewarded for sharing their health data and create a real well evidence database
00:09:39
um and this is a database that will be actors repository for global
00:09:44
data and this is something that's currently missing in health care
00:09:49
um hum and through that we also want to create the did you have platform 'cause this is
00:09:57
the actual application where patients can actually manage their
00:10:01
data they can give access to whatever organisations
00:10:04
the uh you know they would they wish to um patients with with some
00:10:10
of this uh data that's in the monster data for red diseases
00:10:14
if that date is accessed more than these uh patience will be
00:10:17
rewarded more as well so we're creating these digital nuggets essentially
00:10:21
and way using the block chain to be able to track our
00:10:25
g. d. p. r. compliance as well to see where this data is being used who's looked at it
00:10:31
um and also using that as a mechanism for regime as well
00:10:37
this is also platform where patients can be identified by organisations
00:10:43
who seek to a recruit them for a clinical
00:10:46
research studies one additional platform we have is a a
00:10:51
platform pulled of all four crowd funding innovations so
00:10:54
digital asset position and talk in isolation using watching technology to a really effort trot funding value
00:11:01
medical innovation so giving people the public the opportunity to invest in early half technology
00:11:08
and giving a these organisations to receive money quite easily to develop
00:11:13
their products if um and that's it uh thank you
00:11:24
i think you know the question only one
00:11:30
okay willow a ticket from of people and it was big and uh one question
00:11:38
but if you're gonna an important one though it's the the dipper are related
00:11:42
those so used to those some bucks that's in contradictory the
00:11:47
uh with the real to deploy or or buttons
00:11:49
the blue blue's will be a little more or expose it on how exactly
00:11:53
alluded bread compliant but integrating a pageant uh that uh for instance
00:11:59
and the um cody room sure go right to the blue forgotten in regards to which platform to to
00:12:06
your or probably proposal to room norman probably pop proposal
00:12:10
so our main product proposals the pricing platform
00:12:13
and within g. d. p. all the special section for paying for health care um and essentially
00:12:19
the data we poll is essentially all anonymous anyway um so that i sort anonymous
00:12:41
um well i mean to be honest i mean anonymous anonymous them under the way i say it
00:12:45
is essentially the same but that's with the technical teams will do it right i mean
00:12:49
what we need a a a for for paying for health care i mean you don't
00:12:56
need the patient id to pay for the health care we're creating the digital tag
00:13:01
to the certain fields so we can use utilise in utilise nation data and things like that
00:13:07
and also when you start aggregate think data as well then this
00:13:10
ways to actually um use that to paying for health care
00:13:19
yeah no i mean them so that the innate no no i understand understand so we sent to we don't hold
00:13:26
any of this data on the block chain or anything like this this is all held off chain as well
00:13:30
and we have the block chain hold hash is which point to where the status as essentially help
00:13:37
it is a lot less that would get your it you look us dollars
00:13:40
though we don't normal okay so thank you all for the presentation

Share this talk: 


Conference program

Mots de bienvenue
Sébastien Mabillard, CEO | Swiss Digital Health
15 June 2018 · 9:07 a.m.
Mots de bienvenue
Victor Fournier, Chef de Service de la santé publique | Canton du Valais
15 June 2018 · 9:11 a.m.
Mots de bienvenue
Jean-Albert Ferrez, Président | Fondation The Ark
15 June 2018 · 9:19 a.m.
Mots de bienvenue
Laurent Sciboz, directeur Institut Informatique de Gestion | HES-SO Valais/Wallis
15 June 2018 · 9:24 a.m.
L'écosystème d'innovation ouverte du CHU Sainte-Justine: une grande communauté gagnante!
Kathy Malas, resp. de la Plateforme de l’innovation et des Fonctions des maladies chroniques et aiguës | CHU SAINTE-JUSTINE (Canada)
15 June 2018 · 9:33 a.m.
Les livraisons par drones : vers une amélioration de la logistique dans le domaine médical
Janick Mischler, Program Manager | LA POSTE SUISSE
15 June 2018 · 10:07 a.m.
E-health et intégration des soins
Marc Cikes, CEO | MEDBASE ROMANDIE (Suisse)
15 June 2018 · 10:32 a.m.
Questions réponses
Remi Gauchoux, Business Development Director - Carenity
15 June 2018 · 11:46 a.m.
Futur de la santé mobile
Dr. med. Patricia Sigam, CEO & Co-founder, digital Med-Lab
15 June 2018 · 11:54 a.m.
Democratizing Data-Driven Medicine
Tarik Dlala, VP Marketing, Sophia Genetics
15 June 2018 · 12:14 p.m.
Ada inside
Vincent Zimmer, Ada Health, Berlin
15 June 2018 · 12:39 p.m.
biospectal, the optical revolution in hypertension monitoring
Prof. Patrick Schoettker, CMO. Biospectal
15 June 2018 · 2:06 p.m.
3D Printed Medicines: A Digital Pharmacy Era
Sarah Trenfield, MPharm, Senior Formulation Scientist, FabRx Ltd.
15 June 2018 · 2:23 p.m.
The Digipharm experience
Ahmed Abdullah, CEO & co-founder, Digipharm, Basel
15 June 2018 · 2:45 p.m.
Enabling the rehabilitative revolution
Dr. Manfredo Atzori, HES-SO Valais Wallis
15 June 2018 · 3 p.m.
Team Gamified Multi-sensory Stroke Rehab
Jean-Luc Turlan et J-P. Ghobril, Lauréats Arkathon 2018
15 June 2018 · 3:22 p.m.
Secure and Trustable EMR Sharing using Blockchain: Open Challenges and Lessons Learned
Alevtina Dubovitskaya, HES-SO Valais-Wallis
15 June 2018 · 3:38 p.m.
Conclusions
Sébastien Mabillard, CEO | Swiss Digital Health
15 June 2018 · 3:59 p.m.

Recommended talks

Health care is more than medical care!
Prof. Dr. Sebastian Probst, DClinPrac, RN, Professor of tissue viability and wound care at the University of Applied Sciences Western Switzerland, Geneva, Switzerland
5 April 2017 · 2:07 p.m.